HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Molecular correlates of epilepsy in early diagnosed and treated Menkes disease.

Abstract
Epilepsy is a major feature of Menkes disease, an X-linked recessive infantile neurodegenerative disorder caused by mutations in ATP7A, which produces a copper-transporting ATPase. Three prior surveys indicated clinical seizures and electroencephalographic (EEG) abnormalities in a combined 27 of 29 (93%) symptomatic Menkes disease patients diagnosed at 2 months of age or older. To assess the influence of earlier, presymptomatic diagnosis and treatment on seizure semiology and brain electrical activity, we evaluated 71 EEGs in 24 Menkes disease patients who were diagnosed and treated with copper injections in early infancy (≤6 weeks of age), and whose ATP7A mutations we determined. Clinical seizures were observed in only 12.5% (3/24) of these patients, although 46% (11/24) had at least one abnormal EEG tracing, including 50% of patients with large deletions in ATP7A, 50% of those with small deletions, 60% of those with nonsense mutations, and 57% of those with canonical splice junction mutations. In contrast, five patients with mutations shown to retain partial function, either via some correct RNA splicing or residual copper transport capacity, had neither clinical seizures nor EEG abnormalities. Our findings suggest that early diagnosis and treatment improve brain electrical activity and decrease seizure occurrence in classical Menkes disease irrespective of the precise molecular defect. Subjects with ATP7A mutations that retain some function seem particularly well protected by early intervention against the possibility of epilepsy.
AuthorsStephen G Kaler, Clarissa J Liew, Anthony Donsante, Julia D Hicks, Susumu Sato, Jacquelyn C Greenfield
JournalJournal of inherited metabolic disease (J Inherit Metab Dis) Vol. 33 Issue 5 Pg. 583-9 (Oct 2010) ISSN: 1573-2665 [Electronic] United States
PMID20652413 (Publication Type: Journal Article, Research Support, N.I.H., Intramural)
Chemical References
  • Cation Transport Proteins
  • Copper
  • Adenosine Triphosphatases
  • ATP7A protein, human
  • Copper-Transporting ATPases
Topics
  • Adenosine Triphosphatases (genetics)
  • Cation Transport Proteins (genetics)
  • Chi-Square Distribution
  • Copper (administration & dosage)
  • Copper-Transporting ATPases
  • DNA Mutational Analysis
  • Dietary Supplements
  • Early Diagnosis
  • Electroencephalography
  • Epilepsy (enzymology, genetics, mortality, physiopathology, prevention & control)
  • Genetic Predisposition to Disease
  • Humans
  • Infant
  • Infant, Newborn
  • Injections, Subcutaneous
  • Maryland
  • Menkes Kinky Hair Syndrome (complications, diagnosis, enzymology, genetics, mortality, physiopathology, therapy)
  • Mutation
  • Phenotype
  • Predictive Value of Tests
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: